Related Experiment Video

Updated: Aug 7, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes

Hideya Mizuno1, Yong-Yeon Cho, Wei-Ya Ma

  • 1Hormel Institute, University of Minnesota, Austin, Minnesota 55912, USA.

Molecular Carcinogenesis
|November 23, 2005
PubMed

Insights

This study establishes a human cell model for cancer research using HaCaT cells. Epidermal growth factor (EGF) induced transformation, with specific inhibitors affecting cell growth and DNA synthesis pathways.

Area of Science:

  • Oncology
  • Cell Biology
  • Dermatology

Background:

  • Neoplastic transformation mechanisms are crucial for understanding human cancer development.
  • Existing mouse models offer insights, but human cell models are needed for direct relevance.
  • HaCaT cells, a human keratinocyte line, provide a valuable in vitro system.

Purpose of the Study:

  • To establish and validate a human neoplastic transformation model using HaCaT cells.
  • To investigate the role of specific signaling pathways in epidermal growth factor (EGF)-induced transformation.
  • To compare the signaling pathways involved in human versus mouse cell transformation.

Main Methods:

  • Established a neoplastic transformation model using HaCaT human keratinocyte cells.
  • Administered epidermal growth factor (EGF) to induce transformation.
  • Utilized specific inhibitors: PD98059 (MEK inhibitor), SP600125 (JNK inhibitor), and SB203580 (p38 inhibitor).
  • Assessed effects on cell growth, DNA synthesis, and anchorage-independent transformation.

Main Results:

  • EGF treatment induced dose-dependent anchorage-independent transformation in HaCaT cells.
  • MEK and JNK inhibitors decreased cell growth, DNA synthesis, and EGF-induced transformation.
  • Unexpectedly, the p38 inhibitor increased EGF-induced transformation in HaCaT cells, contrasting with mouse models.
  • Extracellular-signal regulated kinase (ERK), JNK, and p38 pathways are implicated in EGF-induced human cell transformation.

Conclusions:

  • HaCaT cells provide a robust in vitro model for studying human neoplastic transformation.
  • ERK and JNK pathways are critical for EGF-induced transformation in human keratinocytes.
  • The p38 pathway exhibits a distinct role in human keratinocyte transformation compared to mouse models.
  • These findings advance the understanding of molecular mechanisms in human cancer development.

More Related Videos

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates08:19

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates

Published on: April 22, 2019

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...